SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 5.797
NA - Nord America 258
AS - Asia 57
OC - Oceania 2
Totale 6.114
Nazione #
IT - Italia 5.697
US - Stati Uniti d'America 253
SE - Svezia 45
CN - Cina 16
IN - India 16
NL - Olanda 13
FI - Finlandia 9
GB - Regno Unito 8
FR - Francia 6
SG - Singapore 6
BE - Belgio 5
HK - Hong Kong 5
CA - Canada 4
DE - Germania 4
IE - Irlanda 4
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
IR - Iran 3
AT - Austria 2
AU - Australia 2
ES - Italia 1
IL - Israele 1
JP - Giappone 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 6.114
Città #
Cagliari 5.640
Chandler 45
Nyköping 41
Fairfield 33
Ashburn 23
Rome 20
New York 17
Boardman 12
Seattle 12
Amsterdam 11
Houston 11
Pune 11
Shanghai 10
Helsinki 9
San Diego 9
Wilmington 8
Woodbridge 7
Boston 6
Cambridge 6
Menlo Park 5
Dong Ket 4
La Maddalena 4
Paris 4
Toronto 4
Peristeri 3
Sassari 3
Delhi 2
Don Mueang 2
Dublin 2
Enna 2
Godo 2
Hefei 2
Hong Kong 2
Islington 2
Leuven 2
Livorno 2
Los Angeles 2
Molenbeek-Saint-Jean 2
Naples 2
Romainville 2
San Francisco 2
Sydney 2
Vienna 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Bilbao 1
Brussels 1
Chandigarh 1
Ebisu 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Heidelberg 1
Hounslow 1
Jacksonville 1
London 1
Miami Beach 1
Milan 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Rockville 1
Sambuca di Sicilia 1
San Mateo 1
Shenzhen 1
South Deerfield 1
Stockholm 1
Tabriz 1
Washington 1
Totale 6.025
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.066
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 581
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 462
Molecular-driven treatment for biliary tract cancer: the promising turning point 454
Uncovering key targets of success for immunotherapy in pancreatic cancer 400
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 393
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 331
BRCA-mutant pancreatic ductal adenocarcinoma 321
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 257
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 254
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 245
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 165
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 158
null 47
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 21
Totale 6.155
Categoria #
all - tutte 9.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/2022892 53 48 3 25 40 78 38 73 63 79 143 249
2022/20232.566 188 345 306 175 170 191 126 215 194 321 205 130
2023/20241.738 95 66 76 119 188 389 361 159 117 156 12 0
Totale 6.155